Arun Sachu, Harisree Sudersanan, Sanjo Sunny, Philip Mathew, Ajeesh Kumar, Alice David
{"title":"Is routine screening for <i>Candida auris</i> necessary in ICU?","authors":"Arun Sachu, Harisree Sudersanan, Sanjo Sunny, Philip Mathew, Ajeesh Kumar, Alice David","doi":"10.18502/ijm.v16i5.16807","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>The capability to cause invasive infection, multi-drug resistance, and health care-associated outbreaks of <i>Candida auris</i> have made it a pathogen of great concern. Estimating how many patients in our intensive care unit had <i>C. auris</i> colonization and what characteristics put patients at risk for having <i>Candida</i> spp. colonization were the primary goals of the study.</p><p><strong>Materials and methods: </strong>Swabs from axilla and groin were collected from 229 patients getting admitted to the ICU. Samples were inoculated into CHROMagar<sup>TM</sup> <i>Candida</i> Plus medium. Colonies presumptively identified as <i>C. auris</i> by the presence of light blue with blue halo and were confirmed by VITEK-2.</p><p><strong>Results: </strong>Our study showed that only one patient was colonized with <i>C. auris</i>. A total of 47 (20.5%) patients were colonized with <i>Candida</i> spp., of which <i>Candida parapislosis</i> was the predominant organism. History of antibiotic use and cerebrovascular accident were independent risk factors in <i>Candida</i> colonization.</p><p><strong>Conclusion: </strong>Active screening for <i>Candida auris</i> in all patients is not required in our hospital as the prevalence was very low and not cost-effective. Therefore we plan to modify our screening strategy and use risk factors based surveillance strategy as it may serve as an ideal strategy.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 5","pages":"708-715"},"PeriodicalIF":1.3000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11551662/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijm.v16i5.16807","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: The capability to cause invasive infection, multi-drug resistance, and health care-associated outbreaks of Candida auris have made it a pathogen of great concern. Estimating how many patients in our intensive care unit had C. auris colonization and what characteristics put patients at risk for having Candida spp. colonization were the primary goals of the study.
Materials and methods: Swabs from axilla and groin were collected from 229 patients getting admitted to the ICU. Samples were inoculated into CHROMagarTMCandida Plus medium. Colonies presumptively identified as C. auris by the presence of light blue with blue halo and were confirmed by VITEK-2.
Results: Our study showed that only one patient was colonized with C. auris. A total of 47 (20.5%) patients were colonized with Candida spp., of which Candida parapislosis was the predominant organism. History of antibiotic use and cerebrovascular accident were independent risk factors in Candida colonization.
Conclusion: Active screening for Candida auris in all patients is not required in our hospital as the prevalence was very low and not cost-effective. Therefore we plan to modify our screening strategy and use risk factors based surveillance strategy as it may serve as an ideal strategy.
期刊介绍:
The Iranian Journal of Microbiology (IJM) is an international, multi-disciplinary, peer-reviewed journal that provides rapid publication of the most advanced scientific research in the areas of basic and applied research on bacteria and other micro-organisms, including bacteria, viruses, yeasts, fungi, microalgae, and protozoa concerning the development of tools for diagnosis and disease control, epidemiology, antimicrobial agents, clinical microbiology, immunology, Genetics, Genomics and Molecular Biology. Contributions may be in the form of original research papers, review articles, short communications, case reports, technical reports, and letters to the Editor. Research findings must be novel and the original data must be available for review by the Editors, if necessary. Studies that are preliminary, of weak originality or merely descriptive as well as negative results are not appropriate for the journal. Papers considered for publication must be unpublished work (except in an abstract form) that is not under consideration for publication anywhere else, and all co-authors should have agreed to the submission. Manuscripts should be written in English.